Multiwave Technologies AG

Multiwave Technologies AG is a Swiss medical imaging company based in Geneva, founded in March 2015.

The company specializes in developing an ultra-portable, ultra-low-field MRI device called MGNTQTM, which utilizes metamaterials and AI software. Their mission is to make MRI accessible globally, focusing on early disease diagnosis and preventive care. The MGNTQTM system provides medical-grade imaging for brain health and other applications, suitable for hospitals, clinics, and remote settings. Multiwave is actively pursuing regulatory approvals, including FDA 510(k) and CE clearance. The company has delivered its first devices to Mount Sinai Hospital in New York and Brighton and Sussex Medical School in the UK. Multiwave Technologies AG operates with a dedicated R&D team and collaborates with academic institutions across Europe. They are committed to interdisciplinary research and have developed additional technologies, including microwave sensors and trans-cranial magnetic stimulation devices. With a focus on global healthcare, the company aims to improve access to medical imaging, particularly in regions with limited resources.